Cerebral proton magnetic resonance spectroscopy demonstrates reversibility of N-acetylaspartate/creatine in gray matter after delayed encephalopathy due to carbon monoxide intoxication: a case report

Journal of Medical Case Reports

Ole Hyldegaard¹  Erik Christian Jansen¹  Vibeke Andree Larsen³  Else Rubæk Danielsen³  Daniel Kondziella²  Marco Bo Hansen¹ 

[1] Hyperbaric Oxygen Treatment Unit, Department of Anesthesia, Centre for Head and Orthopedics, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen DK-2100, Denmark;Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen DK-2100, Denmark;Department of Radiology, Diagnostic Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen DK-2100, Denmark

关键词: N-acetylaspartate;    Choline;    Encephalopathy;    Magnetic resonance imaging;    Magnetic resonance spectroscopy;    CO poisoning;   

Others  :  814057
DOI  :  10.1186/1752-1947-8-211

 received in 2014-02-26, accepted in 2014-04-29,  发布年份 2014

【 摘 要 】

Introduction

Predictive markers for long-term outcome in carbon monoxide-intoxicated patients with late encephalopathy are desired. Here we present the first data demonstrating a full reversibility pattern of specific brain substances measured by cerebral proton magnetic resonance spectroscopy in a carbon monoxide-intoxicated victim. This may provide clinicians with important information when estimating patient outcome.

Case presentation

We report the case of a 40-year-old Caucasian woman with severe carbon monoxide poisoning who was treated with five repetitive sessions of hyperbaric oxygen therapy in a multiplace chamber (100 percent oxygen with a ventilator, 90 minutes exposure to 2.8 atmospheres absolute). Initially, our patient recovered completely after three days of hospitalization, but became encephalopathic after a lucid interval of four weeks. An examination of the brain with cerebral proton magnetic resonance spectroscopy showed a dramatically decrease in N-acetylaspartate to total creatine ratios and elevated lactate levels in the gray matter. Subsequently, our patient received six additional sessions of hyperbaric oxygen therapy with only minimal recovery. At six-month follow-up our patient showed significant improvement in cognition and neuromuscular coordination. Extraordinarily, the cerebral proton magnetic resonance spectroscopy measurements at relapse compared to measurements at follow-up (217 days post insult) revealed full reversal of the severe abnormalities in mid-occipital gray matter and partial reversal in white matter.

Conclusions

The present case indicates that cerebral proton magnetic spectroscopy provides valuable information on brain metabolism in patients presenting with delayed encephalopathy after acute carbon monoxide intoxication. The full reversal of N-acetylaspartate to total creatine ratios in gray matter has, to our knowledge, never been described before and shows that severe, initial measurements may not predict poor long-term patient outcome.

【 授权许可】

   
2014 Hansen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Raub JA, Mathieu-Nolf M, Hampson NB, Thom SR: Carbon monoxide poisoning - a public health perspective. Toxicology 2000, 145:1-14.
• [2]Amitai Y, Zlotogorski Z, Golan-Katzav V, Wexler A, Gross D: Neuropsychological impairment from acute low-level exposure to carbon monoxide. Arch Neurol 1998, 55:845-848.
• [3]Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, Orme JF Jr, Thomas FO, Morris AH: Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002, 347:1057-1067.
• [4]Parkinson RB, Hopkins RO, Cleavinger HB, Weaver LK, Victoroff J, Foley JF, Bigler ED: White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning. Neurology 2002, 58:1525-1532.
• [5]Prockop LD: Carbon monoxide brain toxicity: clinical, magnetic resonance imaging, magnetic resonance spectroscopy, and neuropsychological effects in 9 people. J Neuroimaging 2005, 15:144-149.
• [6]Kondziella D, Danielsen ER, Hansen K, Thomsen C, Jansen EC, Arlien-Soeborg P: 1H MR spectroscopy of gray and white matter in carbon monoxide poisoning. J Neurol 2009, 256:970-979.
• [7]Murata T, Kimura H, Kado H, Omori M, Onizuka J, Takahashi T, Itoh H, Wada Y: Neuronal damage in the interval form of CO poisoning determined by serial diffusion weighted magnetic resonance imaging plus 1H-magnetic resonance spectroscopy. J Neurol Neurosurg Psychiatr 2001, 71:250-253.
• [8]Sakamoto K, Murata T, Omori M, Kimura H, Nishio M, Murata I, Koshino Y, Itoh S, Ishii Y, Isaki K: Clinical studies on three cases of the interval form of carbon monoxide poisoning: serial proton magnetic resonance spectroscopy as a prognostic predictor. Psychiatry Res 1998, 83:179-192.
• [9]Kamada K, Houkin K, Aoki T, Koiwa M, Kashiwaba T, Iwasaki Y, Abe H: Cerebral metabolic changes in delayed carbon monoxide sequelae studied by proton MR spectroscopy. Neuroradiology 1994, 36:104-106.
• [10]Tormoehlen LM: Toxic leukoencephalopathies. Neurol Clin 2011, 29:591-605.
• [11]Martin E, Capone A, Schneider J, Hennig J, Thiel T: Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann Neurol 2001, 49:518-521.
• [12]Danielsen ER, Christensen PB, Arlien-Søborg P, Thomsen C: Axonal recovery after severe traumatic brain injury demonstrated in vivo by 1H MR spectroscopy. Neuroradiology 2003, 45:722-724.
• [13]Zhang J, Piantadosi CA: Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 1992, 90:1193-1199.
• [14]Thom SR, Bhopale VM, Fisher D, Zhang J, Gimotty P: Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci USA 2004, 101:13660-13665.
• [15]Hu H, Pan X, Wan Y, Zhang Q, Liang W: Factors affecting the prognosis of patients with delayed encephalopathy after acute carbon monoxide poisoning. Am J Emerg Med 2011, 29:261-264.
• [16]Lo CP, Chen SY, Chou MC, Wang CY, Lee KW, Hsueh CJ, Chen CY, Huang KL, Huang GS: Diffusion-tensor MR imaging for evaluation of the efficacy of hyperbaric oxygen therapy in patients with delayed neuropsychiatric syndrome caused by carbon monoxide inhalation. Eur J Neurol 2007, 14:777-782.
• [17]Schaller B, Cornelius JF, Sandu N: Molecular medicine successes in neuroscience. Mol Med 2008, 14:361-364.
• [18]Schaller B: Usefulness of positron emission tomography in diagnosis and treatment follow-up of brain tumors. Neurobiol Dis 2004, 15:437-448.
• [19]Whone AL, Moore RY, Piccini PP, Brooks DJ: Plasticity of the nigropallidal pathway in Parkinson’s disease. Ann Neurol 2003, 53:206-213.